Tag: shots

Categories
Business

J&J CEO says individuals might get annual photographs for the subsequent a number of years

J&J CEO says people may get annual shots for the next several years

Johnson & Johnson Chairman and CEO Alex Gorsky celebrates the 75th anniversary of his company’s listing on the New York Stock Exchange on September 17, 2019.

Brendan McDermid | Reuters

People may need to be vaccinated against Covid-19 annually for the next several years, just like they would with seasonal flu shots, Johnson & Johnson CEO Alex Gorsky told CNBC on Tuesday.

“Unfortunately as [the virus] Spreads can also mutate, “he told CNBC’s Meg Tirrell during a Healthy Returns Spotlight event.” Every time it mutates, it’s almost like another click on the dial, so to speak, where we can see another variant, another mutation that can affect its ability to fight off antibodies or not just a therapeutic agent, but also react differently to a vaccine. “

Public health officials and infectious disease experts have indicated that there is a high probability that Covid-19 will become an endemic disease, meaning it will be present in communities at all times, albeit likely at lower levels than it is now. Health officials must constantly look for new variants of the virus so scientists can make vaccines against them, medical experts say.

Gorsky’s comment came after J&J stated it had applied to the Food and Drug Administration for emergency approval for its coronavirus vaccine. Unlike Pfizer and Moderna’s vaccines, which require two doses three to four weeks apart, J&J only requires one dose, which makes logistics easier for healthcare providers.

US officials and Wall Street analysts are eagerly awaiting J & J’s vaccine approval, which could come as early as this month. President Joe Biden is trying to speed up the pace of vaccination in the US, and experts say his government will need a range of drugs and vaccines to beat the virus that killed more than 450,000 Americans last year at Johns Hopkins University .

The Department of Health and Human Services announced in August that it had signed a contract with Janssen, J & J’s pharmaceutical subsidiary, worth approximately $ 1 billion for 100 million doses of its vaccine. The deal gives the federal government the opportunity to order another 200 million cans, according to the announcement.

Gorsky told CNBC that the company’s first priority is to work with the FDA for US approval. He said J&J was “at full speed” making vaccines, adding the company was “extremely confident” of achieving its goal of shipping 100 million doses of its Covid vaccine to the US by the end of June.

“We will keep our commitments while doing everything we can to safely and effectively speed production,” he said, adding that people are “very excited” to get a single shot of the virus.

J&J continues to work on a two-dose coronavirus vaccine, Gorsky said. The company expects two-shot vaccine data from clinical trials in the second half of 2021.

Categories
Health

NY will start providing photographs to folks with underlying well being circumstances this month

NY will begin offering shots to people with underlying health conditions this month

A health care worker gives a picture of Moderna COVID-19 to a woman at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in New York on January 29, 2021 Vaccine.

Facebook Facebook Logo Log in to Facebook to connect with Mike Segar Reuters

New York State plans to take unused Covid-19 vaccine doses from hospitals and distribute them to city and county health officials to distribute to people with underlying health conditions starting Feb.15, Governor Andrew Cuomo said on Friday.

The state has focused on vaccinating its health care workers and residents of long-term care facilities with its initial rations of Covid-19 shots. Now, hospitals have a week to use up their doses for staff before the state transfers the vials to local health departments for people with pre-existing health conditions that put them at high risk of serious illness, Cuomo said.

“Hospitals, you still have a week to get your hospital staff to accept the vaccine and then we will focus on the comorbidities,” Cuomo said at a press conference.

Cuomo didn’t immediately state what health conditions someone would need to get a vaccine, despite saying New York officials are working with the US Centers for Disease Control and Prevention to compile a “comorbidity list.” In January, the federal government, under the former Trump administration, proposed that states open up their vaccination eligibility to people 65 and over and to those with conditions like diabetes.

Later on Friday, the governor released a list of 15 underlying health conditions that would entitle a resident to a sting. Some of these conditions include cancer, heart failure, severe obesity, pregnancy, and diabetes, among others.

The Democratic governor added that the hospitals will continue to receive adequate care to vaccinate “who to do and who to plan and which workers to convince to take it”. All doses above that amount will be given to local health authorities, he said.

To date, New York has administered more than 1.7 million first vaccine doses from Pfizer-BioNTech and Moderna, as well as nearly 500,000 second vaccine doses, according to the Democratic governor. Around 7 million New Yorkers can currently be vaccinated.

Cuomo said the state has used almost all of its allotted doses and is now waiting for next week’s supply.

In mid-January, Cuomo expanded the pool of people eligible for vaccines in New York aged 65 and over, as well as those in certain key industries such as teachers, police and transit workers. However, some residents struggled to sign up for appointments in New York due to limited availability.

“We don’t have an offer that can reach everyone, we understand that,” said Cuomo. “So the prioritization is to reach those people who are most at risk or most important for this period.”

Categories
Business

Fauci says ‘no purple flags’ seen in 10,000 pregnant girls who’ve obtained Covid pictures to this point

Fauci says 'no red flags' seen in 10,000 pregnant women who've received Covid shots so far

The director of the National Institute for Allergies and Infectious Diseases, Dr. Anthony Fauci, speaks during a White House press conference led by White House Press Secretary Jen Psaki in the James Brady Press Briefing Room at the White House January 21, 2021 in Washington, DC.

Alex Wong | Getty Images

“No red flags” have been seen in the more than 10,000 pregnant women who have received Covid-19 vaccinations so far, said White House health advisor Dr. Anthony Fauci, on Wednesday.

Pregnant women and young children were excluded from the original US clinical trials of the vaccines, as is typical in experimental vaccine research. This has raised some concerns that there isn’t enough data to ensure that the vaccines are safe in pregnant women, but Fauci said the Food and Drug Administration hadn’t seen any cause for concern.

“The FDA, as part of the typical follow-up you have after the initial issue of any [emergency use authorization] have found so far and we have to be careful, but so far no red flags about it, about pregnant women, “said Fauci on Wednesday in an interview with Dr. Howard Bauchner of the Journal of the American Medical Association.

Since the approval of the Moderna and Pfizer-BioNTech vaccines in December, over 10,000 pregnant women, many of whom were healthcare workers, have had the chance, Fauci said. He noted that there is evidence that coronavirus infection may lead to an increased risk of an undesirable outcome in pregnancy, which is why many pregnant healthcare workers may have chosen the vaccine.

The Centers for Disease Control and Prevention has recommended that pregnant women should consult their doctor about whether or not to get vaccinated against Covid-19. However, the World Health Organization chose a cautious tone and stated last week that only pregnant women who are at high risk of being exposed to Covid-19 should be vaccinated.

For young children, the FDA has only approved Pfizer’s Covid-19 vaccine for use in people aged 16 and over in the United States. Moderna’s vaccine is only approved for use in people aged 18 and over in the country.

Fauci said “de-escalation studies” for younger children are underway. Such studies will examine the safety and effectiveness of the vaccines in increasingly younger children. Data from these studies should be available “in the next few months,” said Fauci.

“We don’t need to do efficacy studies with 30,000 to 44,000 people in every age group,” he noted.

Categories
Health

How New Vaccine Information Provides Hope for Spring, if Sufficient Individuals Get the Pictures

How New Vaccine News Gives Hope for Spring, if Enough People Get the Shots

Als Anfang November im ganzen Land Coronavirus-Infektionen zunahmen – und sich die Aussicht auf einen langen, dunklen Winter abzeichnete – war nicht klar, ob sich einer der in der Entwicklung befindlichen Impfstoffe durchsetzen würde.

Jetzt, drei Monate später, sieht das Bild ganz anders aus. Im ganzen Land werden zwei hochwirksame Covid-Impfstoffe eingeführt. Drei andere scheinen etwas weniger robust zu sein, bieten aber dennoch einen starken und in einigen Fällen vollständigen Schutz vor schweren Krankheiten und Todesfällen.

Alleine in der vergangenen Woche berichteten Novavax und Johnson & Johnson, dass ihre Impfstoffe einen guten Schutz bieten, auch gegen neue, ansteckendere Varianten des Coronavirus. Eine neue Analyse der Universität Oxford legt nahe, dass der mit AstraZeneca entwickelte Impfstoff die Übertragung verlangsamen kann und besonders gut funktioniert, wenn sich die zweite Dosis verzögert.

Nach einem Sputter-Start beschleunigt sich die Impfung in den USA: Mehr als 27 Millionen Amerikaner haben eine erste Dosis erhalten, und mehr als sechs Millionen wurden vollständig geimpft. Dieses Tempo hat sich so beschleunigt, dass Präsident Biden, der kritisiert wurde, dass das Ziel seiner Regierung, in seinen ersten 100 Tagen im Amt 100 Millionen Schüsse abzugeben, zu bescheiden war, letzte Woche das Ziel auf 150 Millionen Schüsse nach oben korrigierte.

“Wir haben einen langen Weg zurückgelegt”, sagte Akiko Iwasaki, Immunologe an der Yale University. “Wir leben immer noch mit tödlichen Krankheiten, weil wir nicht genug Menschen geimpft haben, aber sobald wir dies tun, wird sich die Art und Weise, wie wir mit diesem Virus leben und umgehen, wirklich ändern.”

Aber auch wenn es im Frühjahr und Sommer Grund zur Hoffnung gibt, bleiben viele Experten des öffentlichen Gesundheitswesens in den nächsten Monaten pessimistisch. Mehrere warnten, dass die Welt bei weitem nicht frei von einer Pandemie sei, bei der in den USA fast 450.000 Menschen und weltweit 2,2 Millionen Menschen ums Leben gekommen seien.

In reichen Ländern haben sich die Impfungen beschleunigt, aber ärmere Länder bleiben zurück. In den Vereinigten Staaten erhalten wohlhabendere weiße Einwohner häufiger Zugang zu dem Impfstoff als Schwarze und Latinos, die überproportional von der Pandemie betroffen sind.

Obwohl die Fälle in den Vereinigten Staaten in den letzten Wochen zurückgegangen sind, befinden sie sich immer noch auf einem Niveau, das fast doppelt so hoch ist wie der Höhepunkt des letzten Sommers, selbst wenn einige Großstädte wie Chicago und New York Speisen im Innenbereich und andere Aktivitäten eröffnen. Die Rücknahme von Beschränkungen kommt auch, da ansteckende neue Varianten den Globus umkreisen, von denen einige die Wirksamkeit der Impfstoffe zu verringern scheinen.

Dr. Eric Topol, Experte für klinische Studien bei Scripps Research in San Diego, erinnerte sich daran, dass er bereits im Dezember hoffnungsvoll war, dass die Pandemie in den USA bis Juni gezähmt werden könnte, dank der Flut ermutigender Impfstoffdaten. Aber als das Bild in den letzten Wochen klarer wurde, was die Bedrohung durch neue, ansteckendere Varianten des Virus betrifft, die sich in anderen Ländern ausbreiten, die in den Vereinigten Staaten aufgetaucht sind – insbesondere die Variante B.1.1.7, die erstmals in Großbritannien – sein Optimismus hat nachgelassen.

“Die Varianten haben alles verändert”, sagte Dr. Topol.

Vorläufige Studien haben gezeigt, dass die Impfstoffe von Pfizer, Moderna, Novavax und Johnson & Johnson gegen die Variante B.1.1.7 zu wirken scheinen und dass sie auch – wenn auch weniger – gegen die erstmals in Südafrika identifizierte Variante wirksam sind. Selbst im Fall dieser Variante zeigte die Studie von Johnson & Johnson, dass sie immer noch vor schweren Krankheiten schützt.

Einige der ersten Menschen, die geimpft wurden, sehen einen Weg aus der Pandemie.

Bei Bloom Senior Living, einer Kette von Seniorenwohneinrichtungen im Südosten und Mittleren Westen, haben Beamte an fünf ihrer neun Standorte nach und nach begonnen, ihre Türen für Besucher in Innenräumen wieder zu öffnen.

Diese Entscheidungen waren auf die Infektionsraten in der Gemeinde zurückzuführen, aber ein weiterer Faktor hat die Beamten von Bloom mit der Idee vertraut gemacht: 96 Prozent der Bewohner von Einrichtungen, die von Apothekenimpfungsteams besucht wurden, haben zugestimmt, einen Schuss zu bekommen.

“Es bedeutet alles für sie, ihre erwachsenen Kinder und hoffentlich schließlich ihre Enkelkinder sehen zu können – um das Gefühl zu haben, wieder ein Leben zu führen”, sagte Bradley Dubin, Direktor der Firma, die die Bloom-Einrichtungen besitzt.

Die Auswirkungen der US-Impfkampagne zeigen sich möglicherweise in den Daten. Die Anzahl der bestätigten Coronavirus-Fälle bei Pflegebewohnern ging in den ersten drei vollen Wochen, in denen Impfstoffe in Pflegeheimen verabreicht wurden, zurück. Dies geht aus Daten hervor, die Pflegeheime den Zentren für die Kontrolle und Prävention von Krankheiten melden. Es ist nicht klar, wie viel davon auf Impfungen zurückzuführen ist.

In Vermont, wo 85 Prozent der Menschen in Langzeitpflegeeinrichtungen zugestimmt haben, mindestens ihren ersten Impfstoff zu bekommen, sagten Beamte diese Woche, dass sie planen, die Besuchsbeschränkungen in diesen Häusern bald zu lockern, obwohl sie dies nicht festgelegt haben ein Datum dafür.

Die Impfkampagne in Pflegeheimen ist Teil einer Impfkampagne in den USA, die nach wochenlangen frustrierenden Verzögerungen an Dynamik gewonnen hat. Die Vereinigten Staaten geben derzeit durchschnittlich 1,3 Millionen Schüsse pro Tag ab, und in einigen Staaten wie Alaska und New Mexico haben mehr als 10 Prozent der Bevölkerung mindestens eine von zwei erforderlichen Dosen eines Impfstoffs erhalten.

Staatliche und lokale Gesundheitsbehörden richten Massenimpfaktionen durch, beispielsweise im Dodger Stadium in Los Angeles, und arbeiten mit der Nationalgarde und der Federal Emergency Management Agency zusammen. Die Kampagne wird auch zunehmend auf Apotheken ausgeweitet, in denen viele Amerikaner daran gewöhnt sind, Impfstoffe zu erhalten.

Auch an der Versorgungsfront gibt es hoffnungsvolle Anzeichen.

Am Dienstag kündigte die Bundesregierung an, den Staaten für die nächsten drei Wochen mindestens 10,5 Millionen Dosen Coronavirus-Impfstoffe zuzuteilen. Gleichzeitig spricht Moderna mit der Food and Drug Administration über die Befüllung der Durchstechflaschen mit 15 statt der derzeit 10 Dosen. Diese Änderung könnte die Produktion des Unternehmens um 50 Prozent steigern.

Darüber hinaus hat Pfizer angekündigt, bis Mai zwei Monate vor dem geplanten Termin 200 Millionen Dosen in die USA liefern zu können, da jetzt eine zusätzliche Dosis in den Impfstoffflaschen gezählt wird.

Covid19 Impfungen >

Antworten auf Ihre Impfstofffragen

Bin ich in meinem Bundesstaat für den Covid-Impfstoff berechtigt?

Derzeit können mehr als 150 Millionen Menschen – fast die Hälfte der Bevölkerung – geimpft werden. Aber jeder Staat trifft die endgültige Entscheidung darüber, wer zuerst geht. Die 21 Millionen Beschäftigten im Gesundheitswesen des Landes und drei Millionen Einwohner von Langzeitpflegeeinrichtungen waren die ersten, die sich qualifizierten. Mitte Januar forderten Bundesbeamte alle Bundesstaaten auf, die Berechtigung für alle über 65-Jährigen und für Erwachsene jeden Alters mit Erkrankungen zu öffnen, bei denen ein hohes Risiko besteht, dass sie schwer krank werden oder an Covid-19 sterben. Erwachsene in der Allgemeinbevölkerung stehen am Ende der Reihe. Wenn Gesundheitsbehörden von Bund und Ländern Engpässe bei der Verteilung von Impfstoffen beseitigen können, sind alle ab 16 Jahren bereits im Frühjahr oder Frühsommer förderfähig. Der Impfstoff wurde bei Kindern nicht zugelassen, obwohl derzeit Studien durchgeführt werden. Es kann Monate dauern, bis ein Impfstoff für Personen unter 16 Jahren verfügbar ist. Aktuelle Informationen zu den Impfrichtlinien in Ihrer Region finden Sie auf Ihrer staatlichen Gesundheitswebsite

Ist der Impfstoff frei?

Sie sollten nichts aus eigener Tasche bezahlen müssen, um den Impfstoff zu erhalten, obwohl Sie nach Versicherungsinformationen gefragt werden. Wenn Sie nicht versichert sind, sollten Sie den Impfstoff trotzdem kostenlos erhalten. Der Kongress hat in diesem Frühjahr ein Gesetz verabschiedet, das es Versicherern verbietet, eine Kostenteilung wie eine Zuzahlung oder einen Selbstbehalt anzuwenden. Es bestand aus zusätzlichen Schutzmaßnahmen, die es Apotheken, Ärzten und Krankenhäusern untersagten, Patienten, einschließlich nicht versicherter Patienten, in Rechnung zu stellen. Trotzdem befürchten Gesundheitsexperten, dass Patienten in Schlupflöcher geraten, die sie für Überraschungsrechnungen anfällig machen. Dies kann bei Personen der Fall sein, denen zusammen mit ihrem Impfstoff eine Arztbesuchsgebühr berechnet wird, oder bei Amerikanern, die bestimmte Arten der Krankenversicherung haben, die nicht unter die neuen Vorschriften fallen. Wenn Sie Ihren Impfstoff von einer Arztpraxis oder einer Notfallklinik erhalten, sprechen Sie mit ihnen über mögliche versteckte Kosten. Um sicherzugehen, dass Sie keine Überraschungsrechnung erhalten, ist es am besten, Ihren Impfstoff an einer Impfstelle des Gesundheitsministeriums oder in einer örtlichen Apotheke zu erhalten, sobald die Aufnahmen breiter verfügbar sind.

Kann ich wählen, welchen Impfstoff ich bekomme?Wie lange hält der Impfstoff? Brauche ich nächstes Jahr noch einen?

Das ist zu bestimmen. Es ist möglich, dass Covid-19-Impfungen genau wie die Grippeimpfung zu einem jährlichen Ereignis werden. Oder es kann sein, dass der Nutzen des Impfstoffs länger als ein Jahr anhält. Wir müssen abwarten, wie dauerhaft der Schutz vor den Impfstoffen ist. Um dies festzustellen, werden Forscher geimpfte Menschen aufspüren, um nach „Durchbruchsfällen“ zu suchen – jenen Menschen, die trotz Impfung an Covid-19 erkranken. Dies ist ein Zeichen für eine Schwächung des Schutzes und gibt Forschern Hinweise darauf, wie lange der Impfstoff hält. Sie werden auch die Spiegel von Antikörpern und T-Zellen im Blut geimpfter Personen überwachen, um festzustellen, ob und wann ein Auffrischungsschuss erforderlich sein könnte. Es ist denkbar, dass Menschen alle paar Monate, einmal im Jahr oder nur alle paar Jahre Booster benötigen. Es geht nur darum, auf die Daten zu warten.

Benötigt mein Arbeitgeber Impfungen?Wo kann ich mehr erfahren?

Hunderte Millionen zusätzlicher Impfstoffdosen von Johnson & Johnson, AstraZeneca und Novavax könnten das Angebot bis zum Sommer weiter ausbauen.

Obwohl die neueren Impfstoffe nicht die gleiche hohe Gesamtwirksamkeit zeigten wie Moderna und Pfizer im letzten Jahr und zwei noch keine Ergebnisse aus ihren klinischen Studien in den USA gemeldet haben, haben mehrere Impfstoffexperten auf ein übersehenes, aber vielversprechendes Detail hingewiesen: Alle Die Impfstoffe haben einen hervorragenden Schutz gegen die schwere Form von Covid-19 gezeigt, die zu Krankenhausaufenthalten und zum Tod führt.

“Was ich vermeiden möchte, ist, dass Menschen bis zum Krankenhausaufenthalt krank werden oder auf tragische Weise von Covid-19 sterben”, sagte Dr. Stefan Baral, Epidemiologe an der Johns Hopkins Bloomberg School of Public Health. Die Nachricht, dass die Impfstoffe vor diesen Ergebnissen schützen, sei “unglaublich erhebend”.

Die Herausforderung besteht jedoch darin, “an einen Punkt zu gelangen, an dem tatsächlich genug Menschen geimpft werden können, um diese Vorteile auf Bevölkerungsebene zu sehen”, sagte Angela Rasmussen, Virologin am Center for Global Health Science and Security der Georgetown University. “Meine derzeit größte Sorge ist, dass die Menschen nicht die Vorsichtsmaßnahmen treffen, die sie kurzfristig treffen sollten, damit wir in den kommenden Monaten bequem an diesen Punkt gelangen können.”

Experten haben gesagt, es sei noch zu früh, um die allgemeinen Auswirkungen der Massenimpfung auf die öffentliche Gesundheit in den USA zu erkennen. Aber ein anderes Land – Israel – bietet Hoffnung. Forscher in diesem Land, das weltweit führend bei der Impfung seiner Bevölkerung ist, haben nach nur einer Dosis Pfizers Schuss einen signifikanten Rückgang der Infektion und nach zwei Schüssen bessere Ergebnisse als erwartet gemeldet, vorläufige Daten, die Experten als ermutigend beschrieben haben.

“Dies ist, was passieren kann, wenn die Dinge richtig laufen”, sagte Dr. Iwasaki aus Yale.

Um dieses Ziel zu erreichen, müssen die Vereinigten Staaten jedoch schnell handeln und das Virus in Schach halten, da hoch ansteckende Varianten häufiger auftreten.

Die Gesundheitsbehörden müssen auch den Zugang zu den Impfstoffen für diejenigen verbessern, die am anfälligsten für Covid-19 sind. Frühe Impfdaten, die unvollständig sind, zeigen, dass Menschen aus wohlhabenderen, weißen Gegenden Impfterminsysteme überflutet haben und einen übergroßen Anteil am begrenzten Angebot haben.

Die gleiche Dynamik spielt sich auch global ab. Wohlhabende Länder haben einen Großteil des weltweiten Impfstoffangebots gekauft, was bedeutet, dass viele ärmere Länder bei der Impfung ihrer Bürger wahrscheinlich zurückbleiben werden. Am Mittwoch kündigte ein internationales Programm zur kostengünstigen oder kostenlosen Lieferung von Covid-19-Impfstoffen an Länder auf der ganzen Welt Pläne an, bis zum 30. Juni mehr als 300 Millionen Dosen abzugeben. Dies reicht jedoch nicht aus, um alle zu impfen.

“Ich denke, in der reichen Welt haben wir ein gutes Gefühl für Impfstoffe, aber weltweit ist es eine andere Geschichte”, sagte Marc Lipsitch, Professor für Epidemiologie und Direktor des Zentrums für Dynamik übertragbarer Krankheiten an der Harvard TH Chan School of Gesundheitswesen.

Dr. Baral von Johns Hopkins kümmert sich um die Bewohner mehrerer Obdachlosenunterkünfte in Toronto. Letzten Monat, sagte er, habe er Bewohner in einem Tierheim für ältere Männer geimpft. “Es war dieses unglaubliche Gefühl der Erleichterung – man konnte es auf ihren Gesichtern sehen”, sagte er. “Wir sind an einem anderen Ort als vor sechs Monaten.”

Categories
Business

This can ‘not be our solely set of pictures,’ says physician

Moderna working on booster shots for South African strain

Former Obama administration official Dr. Kavita Patel told CNBC’s “The News with Shepard Smith” that the number of Covid or booster vaccinations people need “depends on what we see with these strains and how much they escape the immune system”.

Moderna announced on Monday that it was working on updating its Covid vaccine. The company’s researchers said its current shot may be less effective against the South African tribe, also known as the 501Y.V2 variant. The variant is 50% more contagious and has been detected in more than two dozen countries.

Patel, who served in the Obama administration as political director for the Bureau of Intergovernmental Affairs and Public Engagement, told host Shepard Smith that the announcement of Moderna’s vaccine came as no surprise.

“We all suspected that this would not be our only recording, whatever we get this year,” said Patel. “I think it suggests something or a booster at least possibly every few years.”

The Minnesota Department of Health announced Monday that the state has a confirmed case of the highly communicable P.1 variant, also known as B.1.1.248. It was first discovered in northern Brazil in mid-December.

The mutated strains of Covid have led to important measures to combat the spread of the virus. President Joe Biden has reimposed travel bans from nearly 30 countries, including the UK, Brazil and South Africa, to curb new variants. Dr. Anthony Fauci described the travel ban on Monday’s Today Show as “prudent”. He added that travelers must show a negative Covid test before getting on a plane flying to the United States

Despite the new strains of Covid, Patel told host Shepard Smith that “hopefully the worst is behind us” when it comes to the pandemic.

“It looks like we’ve gone past the crest or the climax of that post-vacation spike that we were really worried about,” said Patel during an interview Monday night. “Could we see something worse anytime soon? Very unlikely given that we have two incredibly effective vaccines available.”

Covid cases, hospitalizations and death rates have all been lower since their highs, according to a CNBC analysis of the Johns Hopkins data. There are 110,628 hospital admissions, the lowest in more than a month. The daily average of cases is down 31% in the past 2 weeks and is at its lowest level in 2 months. The daily average of deaths is 3,088, which is slightly below the most recent high 10 days ago, but still averages over 3,000 per day for 17 consecutive days. More than 73,000 Americans died this month. That’s almost the combined deaths in the US in the Korean and Vietnam wars.

Patel noted that it is important to get current vaccines “into people’s arms as soon as possible” and that the vaccines from Johnson & Johnson and Novavax “will hopefully soon help arm our vaccine technology.”

Categories
Business

Moderna engaged on booster pictures for South African pressure

Moderna working on booster shots for South African strain

Moderna said Monday it was speeding up work on a Covid-19 booster shot to protect against the recently discovered variant in South Africa.

The researchers said that the current coronavirus vaccine appears to work against the two highly communicable strains found in the UK and South Africa, although it may be less effective against the latter.

The two-dose vaccine produced an antibody response against several variants, including B.1.1.7 and B.1.351, which were first identified in the UK and South Africa, respectively. This was the result of a Moderna study carried out in collaboration with the National Institute of Allergy and Infectious Diseases. The study has not yet been peer-reviewed.

The vaccine produced a weaker immune response against the South African tribe, but the antibodies remained above levels expected to protect against the virus, the company said, adding that the results may indicate a “potential risk of previous weight loss of immunity to the new “indicate B.1.351 strains.

“Out of caution and taking advantage of the flexibility of our mRNA platform, we are bringing an ambitious variant booster candidate against the variant first identified in the Republic of South Africa to the clinic in order to determine whether it is more effective to increase the titre against it.” these and possibly future variants, “said Stephane Bancel, CEO of Moderna, in a statement.

Moderna shares rose nearly 4% in premarket trading after the announcement.

Paul Offit, director of the Vaccine Education Center at Philadelphia Children’s Hospital, said he was glad Moderna is preparing for the possibility that the virus could mutate enough to evade the protection of current vaccines.

“This is not yet a problem,” said Offit, also a member of the FDA’s Advisory Committee on Vaccines and Related Biological Products. “Prepare for it. Sequencing these viruses. Be ready in case a variant appears that is resistance to the vaccine.”

On Thursday, White House health advisor Dr. Anthony Fauci, new data showed that the Covid-19 vaccines currently on the market may not be as effective against new, more contagious strains of the coronavirus. Some early results posted on the bioRxiv preprint server indicate that the South African variant can evade the antibodies of some coronavirus treatments.

The Food and Drug Administration approved Moderna’s vaccine for people aged 18 and over in December.

Moderna’s vaccine, like Pfizer’s, uses messenger RNA or mRNA technology. It’s a new approach to vaccines that uses genetic material to trigger an immune response. Late-stage clinical trial data released in November shows that Moderna Covid’s vaccine is more than 94% effective at preventing, safe and appearing to ward off serious illness. For maximum effectiveness, the vaccine requires two doses four weeks apart.

Bancel told CNBC that Moderna’s vaccine will protect against the South African tribe in the short term, but the company doesn’t know how long that protection could last.

“What is currently unknown is what will happen in six months, twelve months, especially in the elderly because, as you know, they have weaker immune systems,” he said during an interview with Squawk Box. “Because of this unknown … we decided, out of caution, to bring a new vaccine to the clinic.”

“We cannot lag behind. We cannot fall behind this virus,” he said, adding that the virus “will continue to mutate”.

–CNBC’s Noah Higgins-Dunn contributed to this report.

Categories
Health

CDC modifications Covid vaccine steerage to OK mixing Pfizer and Moderna pictures

CDC changes Covid vaccine guidance to OK mixing Pfizer and Moderna shots

Syringe containers for the Covid-19 vaccines from Pfizer BioNtech and Moderna Inc. in Tucson, Arizona, USA, on Friday, January 15, 2021.

Cherry Orr | Bloomberg | Getty Images

The Centers for Disease Control and Prevention have tacitly changed their guidelines for Covid-19 vaccine shots, stating that it is now okay to mix Pfizer and Moderna shots in “exceptional situations” and that it is in Okay, wait up to six weeks to get the second shot. Two-dose immunization from both companies.

While Pfizer and Moderna’s vaccines, both of which use messenger RNA technology, were approved 21 and 28 days apart, the agency now says that under new guidelines, you can get both shots as long as they’re at least apart 28 days administered will be published on its website Thursday.

Although “every effort” should be made to ensure that a patient receives the same vaccine, in rare situations “any available mRNA COVID-19 vaccine can be administered with a minimum of 28 days between doses” – if supply Is limited or the patient does not know what vaccine they originally received, the CDC says in new guidelines.

The CDC says the two products are not interchangeable, admitting that they hadn’t yet investigated whether their new recommendations would alter the safety or effectiveness of either vaccine.

The agency said health care providers should give patients a vaccination card detailing when they received their first shot and what type of shot it was to ensure patients know which shot to receive the second time. The agency also recommends providers to record the patient’s vaccination information on their medical records and on the government vaccination information system.

Both companies need two doses to achieve maximum protection against the coronavirus. While both shots should be administered according to the guidelines originally recommended, the CDC said the second dose of both companies’ vaccine could be delayed for up to six weeks if necessary.

The updated guidelines come as some cities and counties across the country cancel vaccination appointments because they don’t have as many doses as they originally expected.

Wayne County, Michigan, for example, said last week it would be a priority to make sure people who got their first shot get their second shot on time. But the county said it had to cancel nearly 1,400 appointments for people to get their first shot.

“The intent is not to suggest people do something else, but rather to give clinicians flexibility in exceptional circumstances,” said Jason McDonald, a CDC spokesman, in an email to CNBC.

Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, was asked on Friday about the interval at which the two shots should be administered.

“The data we have is of a two-dose vaccine on the recommended schedule of 21 or 28 days,” she said at a virtual event hosted by Harvard TH Chan School of Public Health and National Public Radio . “At this point in time, we at CDC agree with what the FDA says, and the FDA has made it very clear that we should be using the approved regimen.”

“It’s firmly ingrained in science and the evidence available, and doing anything else would not follow science and possibly not allow us to really get the full potential of these vaccines,” she added. “For now, from the CDC’s point of view, we think it has to be two doses on the recommended schedule.”

Categories
Health

Some Medical College students Wait in Line for Covid Vaccine, Whereas Others Share Selfies of Photographs

Some Medical Students Wait in Line for Covid Vaccine, While Others Share Selfies of Shots

In early January, Nali Gillespie watched her social media feed fill with vaccine selfies: photo after photo of peers at other medical schools across the country proudly posing next to a syringe with their dose of either Moderna or Pfizer Covid-19 vaccine .

But Ms. Gillespie, who is in her third year at Duke University School of Medicine and focused more on research than clinical training, knew she wouldn’t be able to join them just yet.

Since she only volunteers to go to an ambulance once a week, she is less exposed to Covid patients and waits in line behind classmates who work in intensive care units and emergency rooms.

“You hear that in some schools, students are getting their second dose and then there are some of us who are not even scheduled for our first,” said Ms Gillespie.

When she does her weekly shift, she knows that she is still prone to exposure to the coronavirus. “You are becoming increasingly aware that an asymptomatic patient can come into the clinic and you see them in a small exam room,” she said. “The risk is very real.”

In December, the Centers for Disease Control and Prevention announced guidelines prioritizing who should receive vaccines first at the start of the rollout. Although the guidelines were broad, medical students learned that they could join the first wave of healthcare workers, particularly those involved in caring for Covid patients. However, the rollout has varied widely across the country’s 155 medical schools, each of which has prioritized based on the availability of vaccine doses in their state.

This has created stress for some medical students as they continue their clinical rotations. Although some schools prohibit students from treating Covid patients, enforcing this rule can be difficult, especially in asymptomatic cases.

Covid19 vaccinations>

Answers to your vaccine questions

If I live in the US, when can I get the vaccine?

While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.

When can I get back to normal life after the vaccination?

Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild symptoms or no symptoms at all. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.

Do I still have to wear a mask after the vaccination?

Yeah, but not forever. The two vaccines that may be approved this month clearly protect people from contracting Covid-19. However, the clinical trials that produced these results were not designed to determine whether vaccinated people could still spread the coronavirus without developing symptoms. That remains a possibility. We know that people who are naturally infected with the coronavirus can spread it without experiencing a cough or other symptoms. Researchers will study this question intensively when the vaccines are introduced. In the meantime, self-vaccinated people need to think of themselves as potential spreaders.

Will it hurt What are the side effects?

The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection is no different from the ones you received before. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. However, some of them have experienced short-lived symptoms, including pain and flu-like symptoms that usually last a day. It is possible that people will have to plan to take a day off or go to school after the second shot. While these experiences are not pleasant, they are a good sign: they are the result of your own immune system’s encounter with the vaccine and a strong response that ensures lasting immunity.

Will mRNA vaccines change my genes?

No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given moment, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can hold for a few days at most before it is destroyed.

In some facilities, such as the Duke School of Medicine, students working in intensive care units and emergency rooms were placed in priority group 1A with the highest level, while everyone else was told they would be vaccinated under group 1B. At the Yale School of Medicine, all medical students, regardless of their exposure to patients, were told that they would be vaccinated in reverse alphabetical order (“by the first letter of their last name starting at the end of the alphabet”).

“Those in the later stages of the alphabet were happy, but a little confused by how arbitrary it was,” said Sumun Khetpal, a fourth-year student.

Students at Texas College of Osteopathic Medicine in Fort Worth said they had received no notice from the school for weeks when they would receive their vaccines. Some drove around the state for hours looking for private pharmacists who would give them shots. And at the University of Pittsburgh Medical School, students said they also had to “take matters into their own hands” and contact private pharmacies to inquire about a vaccination since they were not told until last weekend how to get vaccines their school.

“The CDC guidelines did not have the granularity that hospitals and schools need to make decisions,” said Dr. Alison Whelan, Scientific Director, Association of American Medical Colleges. “There was considerable variability in the absence of a national plan.”

In addition to the confusion, vaccines have been assigned to states based on population, which does not always reflect the population of health care workers, added Dr. Janis Orlowski, Chief Health Care Officer of the association, added. There are 21,000 medical students in the country.

There is a sense of guilty relief for some of them to have received the vaccine knowing that some of their colleagues have not yet done so.

“One of my close friends is a dentist and has a regular mouth, but she didn’t get the Covid vaccine,” said Azan Virji, a sophomore at Harvard who got his first dose late December. “It feels like there is an inequality.”

Even so, Mr Virji said he had treated Covid-19 patients many times and felt a weight lift because he knew he was now vaccinated.

“My parents in Tanzania may not have access to this vaccine until 2022, and now I’ll be one of the first to have access,” he said. “It’s bittersweet, but it’s important that I feel calmer in the hospital.”

Categories
Health

Moderna seems to be to check Covid-19 booster photographs a yr after preliminary vaccination

Moderna looks to test Covid-19 booster shots a year after initial vaccination

One of the boxes containing the Moderna COVID-19 vaccine is prepared for shipment at the McKesson distribution center in Olive Branch, Mississippi, USA, on December 20, 2020.

Paul Sancya | Reuters

Moderna plans to test a booster shot of its Covid-19 vaccine a year after the first two-dose immunization, as the duration of protection from the new vaccines is still unclear.

The biotech company plans to start the study in July. This emerges from a company presentation at the JPMorgan Healthcare Conference on Monday. According to an email shared by one of those people, employees at the clinical trial sites have already started contacting participants in previous trials.

“From what we’ve seen so far, we’re assuming the vaccination will take at least a year,” said Dr. Tal Zaks, Moderna’s Chief Medical Officer, told investors and analysts at the conference. “To the extent that you need a booster shot, we make a data-based recommendation, and for that we need to pull the data.”

The first participants in Moderna’s human clinical trials received their recordings in mid-March. a second was given four weeks later. Since multiple doses of the vaccine were tested in previous studies, those with doses lower than the ultimately approved – 100 micrograms – would get their booster sooner, while those with 100 micrograms or higher would get their booster at the end of the year, according to an email to the Attendees.

The booster that is now planned is the same version of the vaccine that is on the market, but Stephane Bancel, CEO of Moderna, said it might be necessary to adapt the vaccine in the coming years to cover new variants.

“I think this is going to be a market like the flu,” he told CNBC. Moderna also recently started a seasonal flu vaccination program.

The booster study for Moderna’s Covid-19 vaccine will assess both safety and the immune response that an additional shot generates a year later, Bancel said at the conference.

Categories
Health

U.S. to vary allocation to favor states that shortly administer photographs

U.S. to change allocation to favor states that quickly administer shots

The federal government is changing the way coronavirus vaccine doses are allocated, now based on how quickly states can administer shots and how large their elderly population is, Minister of Health and Human Services Alex Azar said Tuesday.

States have two weeks to prepare for the change, Azar told reporters during a news conference. This should give states enough time to report their data to the government and ensure that all vaccinations are documented “promptly,” he said.

States are currently not reporting vaccinations in a timely manner, Azar said, adding that vaccine doses “sit in hospital freezers”.

The announcement comes as the Centers for Disease Control and Prevention issues new guidelines that extend eligibility for coronavirus vaccines to anyone over 65, as well as those with comorbid conditions like diabetes and heart disease. States’ focus on vaccinating health workers and nursing homes has created a bottleneck that is slowing the pace of vaccination, a senior administrative official told CNBC.

“The states should not wait to complete the prioritization of phase 1a before moving on to broader categories of eligibility,” said Azar on Tuesday the new guidelines. “Think of it like getting on a plane. You may have a sequential order in which you board people. But you don’t wait for literally every person in a group to board before moving on to the next . ”

The Trump administration will also stop withholding millions of doses reserved for the second round of vaccinations with Pfizer’s and Moderna’s two-dose vaccines, the official said, adding it released doses that were held in reserve Sunday . President-elect Joe Biden’s transition team announced a similar plan on Friday.

Approximately 53 million Americans 65 and older and 110 million people 16 to 64 years old with comorbid conditions can now get the vaccine if each state adopts the CDC guidelines.

The vaccine doses were previously assigned based on the number of adults in each state. But US officials complain that the pace of vaccinations has been too slow as the supply of vaccine doses exceeds demand.

Arkansas and Georgia are the two worst performers, vaccinating 1,355 and 1,346 people per 100,000, respectively, according to CDC data. The Dakotas and West Virginia now fire more than 5,000 shots per 100,000 people, according to the agency.

As of Monday morning, more than 25.4 million doses had been distributed in the US, but just over 8.9 million shots had been administered according to CDC data. The number is a far cry from the federal government’s goal of vaccinating 20 million Americans by the end of 2020 and 50 million Americans by the end of this month.

State and local health officials have said they are strapped for cash. They blame insufficient funding and inconsistent communication from the federal government for the slow roll-out.

To speed up the pace of vaccinations, Dr. Stephen Hahn, Commissioner for the Azar and Food and Drug Administration, told states last week to begin vaccinating lower priority groups against Covid-19.

The CDC recommended immunizing health care workers and nursing homes first, but states are free to distribute the vaccine at their discretion. Hahn told reporters that states should give shots to groups that “make sense” such as the elderly, people with pre-existing conditions, police, fire departments and other key workers.

Azar admitted on Tuesday that the government’s guidelines are new, adding that vendors typically have a month to report their data instead of days. “This is a big change in the workflow for them. There will be kinks in the system for them in relation to this data,” he said.